FDA Investigator Amy C Jordan
Amy C Jordan has conducted inspections on 46 sites in 1 countries as of 10 Oct 2012. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
46
Last Inspection Date:
10 Oct 2012
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Amy C Jordan:
Abby E Pelletier,
Alice C Silva,
Alice Canty,
Allison A Rodriguez,
Almaris N Alonso,
Alois P Provost,
Alysia M Salonia,
Amber G Wardwell,
Amy N Chen,
Andrew M Barlow,
Angela J Davis,
Annet R Rajan,
Anthony C Warchut,
Arie C Menachem,
Ashley M Whitehurst,
Brenda P King,
Brenna L Macdowell,
Burnell M Henry,
Calvin B Koerner,
Camerson E Moore,
Carla C Cummins,
Carla C Tuite,
Carlos Chavez,
Cassandra L Abellard,
CDR Jeremy L Wally, PhD,
Charisse K Green,
Christian D Lynch (CDL),
Christopher M Elliott,
Constance Desimone,
Courtney N Long,
Daniel L Zheng,
Darin S Wiegers,
Daryl A Dewoskin,
David P Vanhouten,
Diane C Thibodeau,
Dien N Nguyen,
Donald C Obenhuber, PhD,
Douglas S Joslin,
Dr. Sriram Subramaniam, PhD,
Dr. Zhihao Qiu (Peter), PhD,
Edmund F Mrak, Jr,
Elizabeth B Griffin,
Elizabeth Ll Edwards,
Ellen P Madigan,
Felix Maldonado,
Garry H Stewart,
Gary J Hagan,
Gerard D Difiore,
Jacek Cieslak, PhD,
James W Whitney,
Jason A Rossi,
Jayaleka J Amarasinghe,
John A Sciacchitano,
John P Mistler,
John P Shelton,
John R Carlson,
John S Hartford,
Jonah S Ufferfilge,
Jonathan G Matrisciano,
José E Meléndez,
Joseph H Procopio, Jr,
Joyce A Kellett,
Julie D Bringger,
Justine M Corson,
Karen A Briggs,
Karen Mcnabb Noon,
Kathleen E Mcafoose,
Kent A Conforti,
Kim Lthomas Cruse,
Kristina J Donohue,
Lauren M Lawrance,
LCDR Debra Emerson,
Leanna M Slarsky,
Lei Zhang, PhD,
Leiyun Boone, PhD,
Leo B Zadecky,
Liz M Otero,
Lori M Newman,
Louis Christy,
Margaret E Walsh,
Margaret M Sands,
Maria Joselopez Barragan, PhD,
Mark R Mcclain,
Martin J Guardia,
Mary Jeanet Mcgarry,
Matthew C Watson,
Matthew D Silverman,
Maya M Davis,
Megan A Haggerty,
Meredith L Miller,
Michael J Casey,
Michael L Casner,
Michael Shanks, MS,
Michelle M Noe Varga,
Michelle Yclark Stuart,
Mihaly S Ligmond,
Nabil Nakhoul,
Nancy M Espinal,
Nealie C Newberger,
Nichole B Murphy,
Omotunde O Osunsanmi,
Pamela L Lee,
Pamela L Ogonowski,
Paraluman S Leonin,
Paul P Geraci,
Paula M Laplant,
Philip H Lafleur,
Philip Kreiter,
Phillip E Mclaughlin,
Prabhu P Raju,
Ramon E Martinez,
Reyes Candau Chacon, PhD,
Richard B Mcaroy,
Richard H Penta,
Richard L Friedman,
Richard Ledwidge (nmi), PhD,
Robert D Tollefsen,
Robert J Martin,
Robert Jennings,
Robert O'brian,
Rory K Geyer,
Saleem A Akhtar,
Sandra P White,
Sean R Marcsisin,
Shawn M Bogdan,
Slater K Bartlett,
Stacey S Degarmo,
Stephen D Brown,
Steven Fong, MS, PhD,
Susanne M Richardson, MS RAC,
Suzanne M Healy,
Tanya R Syffrard,
Teddy Tom,
Thomas Cote,
Thomas Siebertz,
Thomas W Nerney,
Uttaniti Limchumroon (Tom),
Victor J Gangi,
Victoria M Daddeo,
Wayne E Seifert,
William Hallett, PhD,
William J Leonard,
Xiaokuang Lai, PhD,
Yetao Jin, PhD,
Yvonne Y Wu,
Zhongren Wu,
Ziyang Su, PhD
Amy C Jordan's Documents
| Publish Date | Document Type | Title |
|---|---|---|
| November, 2012 | FDA 483 | Ameridose, LLC - Form 483, 2012-11-09 |
| August, 2012 | FDA 483 | Tender Corporation - Form 483, 2012-08-17 |
| July, 2012 | FDA 483 | Specialty Minerals Incorporated - Form 483, 2012-07-24 |
| January, 2011 | FDA 483 | Braintree Laboratories, Inc. - Form 483, 2011-01-21 |
| January, 2010 | FDA 483 | The Gillette Company - Form 483, 2010-01-29 |
| April, 2011 | FDA 483 | Sunovion Pharmaceuticals Inc. - Form 483, 2011-04-20 |
| July, 2011 | FDA 483 | Lantheus Medical Imaging, Inc. - Form 483, 2011-07-18 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more